Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| Pomalidomide-C2-NH2；Cereblon Ligand-Linker Conjugates 15;4-[(2-Aminoethyl)amino]-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione | C15H16N4O4 | 1957235-66-3 | Details |
| E3 ligase Ligand 18 | C17H17ClN6O4S | 2241669-88-3 | Details |
| VH032-cyclopropane-F | C26H33FN4O5S | 2306193-99-5 | Details |
| E3 ligase Ligand 8 | C31H34N2O6 | 1225383-33-4 | Details |
| Tazemetostat | C34H44N4O4 | 1403254-99-8 | Details |
| E3 ligase Ligand 9 | C21H32N2O6 | 87304-15-2 | Details |
| cIAP1 Ligand-Linker Conjugates 15 hydrochloride；E3 ligase Ligand-Linker Conjugates 34 hydrochloride | C37H48ClN3O8 | 1225383-36-7 | Details |
| cIAP1 Ligand-Linker Conjugates 11；E3 ligase Ligand-Linker Conjugates 33 | C35H43N3O7 | 1239943-19-1 | Details |
| cIAP1 Ligand-Linker Conjugates 11 Hydrochloride；E3 ligase Ligand-Linker Conjugates 33 Hydrochloride | C35H44ClN3O7 | 1239866-59-1 | Details |
| Pomalidomide-PEG3-C2-NH2；E3 ligase Ligand-Linker Conjugates 30;Cereblon Ligand-Linker Conjugates 5 | C21H28N4O7 | 2093416-31-8 | Details |
| (S,R,S)-AHPC-C10-NH2；VH032-C10-NH2 | C33H51N5O4S | 2341796-74-3 | Details |
| cIAP1 Ligand-Linker Conjugates 15；E3 ligase Ligand-Linker Conjugates 34 | C37H47N3O8 | 1225433-96-4 | Details |
| cIAP1 Ligand-Linker Conjugates 14；E3 ligase Ligand-Linker Conjugates 36 | C39H49N3O10 | 1351169-40-8 | Details |
| Obeticholic Acid | C26H44O4 | 459789-99-2 | Details |
| cIAP1 ligand 2；E3 ligase Ligand 11 | C34H40N4O6S | 2357114-70-4 | Details |
| cIAP1 ligand 1；E3 ligase Ligand 12 | C31H42N4O6S | 2095244-42-9 | Details |
| E3 ligase Ligand 14 | C38H52N4O7 | 2241489-43-8 | Details |
| (4R,5S)-nutlin carboxylic acid；MDM2 ligand 2;E3 ligase Ligand 15 | C32 H32 Cl2 N4 O6 | 2306390-08-7 | Details |
| Nutlin carboxylic acid；MDM2 ligand 1;E3 ligase Ligand 16 | C32H32Cl2N4O6 | 2249750-27-2 | Details |
| Levobupivacaine | C18H28N2O | 27262-47-1 | Details |
| DBCO-PEG9-amine | C39H57N3O11 | 2353409-99-9 | Details |
| DBCO-PEG6-amine | C33H45N3O8 | 2353409-98-8 | Details |
| DSPE-PEG4-acid | C52H100NO15P | 2112738-58-4 | Details |
| DSPE-PEG5-azide | C54H105N4O14P | 2112737-73-0 | Details |
| DSPE-PEG5-propargyl | C55H104NO14P | 2112737-93-4 | Details |
| DSPE-PEG8-Mal | C64H119N2O19P | 2112737-94-5 | Details |
| E3 ligase Ligand 10 | C47H52N4O7 | 1073560-68-5 | Details |
| DSPE-PEG4-DBCO | C71H116N3O15P | 2112738-14-2 | Details |
| Daclatasvir dihydrochloride | C40H51ClN8O6 | 1009119-65-6 | Details |
| DBCO-PEG9-DBCO | C58H70N4O13 | 2353409-50-2 | Details |
| Thalidomide-O-amido-C4-NH2；Cereblon Ligand-Linker Conjugates 6;E3 Ligase Ligand-Linker Conjugates 19 | C19H22N4O6 | 1799711-24-2 | Details |
| Thalidomide-O-amido-C8-NH2；E3 Ligase Ligand-Linker Conjugates 20;Cereblon Ligand-Linker Conjugates 2 | C23H30N4O6 | 1950635-15-0 | Details |
| Dde Biotin-PEG4-TAMRA-PEG4 Alkyne | C72H100N9O18S+ | 2353409-55-7 | Details |
| Di(N-succinimidyl)adipate | C14H16N2O8 | 59156-70-6 | Details |
| Diketone-PEG4-Biotin | C33H50N4O9S | 2353409-85-3 | Details |
| Diketone-PEG4-PFP ester | C30H34F5NO9 | 2353409-84-2 | Details |
| DM4-SMCC | C54H72ClN5O16S | 1228105-52-9 | Details |
| DM4-SPDP | C45H61ClN4O14S2 | 2245698-48-8 | Details |
| DMAC-PDB | C12H16N2O3S2 | 663599-04-0 | Details |
| DMAC-SPP | C17H21N3O5S2 | 663599-10-8 | Details |
| Diethylene glycol bis(p-toluenesulfonate) | C18H22O7S2 | 7460-82-4 | Details |
| DOTA-NHS-ester | C20H31N5O10 | 170908-81-3 | Details |
| Everolimus | C53H83NO14 | 159351-69-6 | Details |
| LXR-623 | C21H12ClF5N2 | 875787-07-8 | Details |
| Canagliflozin | C24H25FO5S | 842133-18-0 | Details |
| GW9508 | C22H21NO3 | 885101-89-3 | Details |
| DNP-PEG4-DBCO | C35H39N5O10 | 2149585-17-9 | Details |
| DBCO-PEG5-DBCO | C50H54N4O9 | 2363130-04-3 | Details |
| exo BCN-O-PNB | C17H17NO5 | 1380006-72-3 | Details |
| FAK ligand-Linker Conjugate 1 | C25H28F3N5O6S | 2307461-45-4 | Details |
| endo-BCN-PEG3-NH2 | C19H32N2O5 | 1883512-27-3 | Details |
| endo-BCN-PEG3-NHS ester | C24H34N2O9 | 2101206-94-2 | Details |
| Estrone-N-O-C1-amido；ERα ligand 1 | C20H26N2O3 | 138219-84-8 | Details |
| Micafungin sodium | C56H72N9NaO23S | 208538-73-2 | Details |
| Fluorescein-PEG5-NHS ester | C38H41N3O14S | 2353409-62-6 | Details |
| Fmoc-Ala-Ala-Asn-PABC-PNP | C39H38N6O11 | 1834516-06-1 | Details |
| cIAP1 Ligand-Linker Conjugates 2；E3 ligase Ligand-Linker Conjugates 37 | C37H48N4O7 | 1312302-14-9 | Details |
| Pomalidomide-PEG1-C2-N3；Cereblon Ligand-Linker Conjugates 13;E3 ligase Ligand-Linker Conjugates 50 | C17H18N6O5 | 2271036-44-1 | Details |
| VHL Ligand-Linker Conjugates 15；E3 Ligase Ligand-Linker Conjugates 56 | C37H45FN4O8S | 2375564-62-6 | Details |
| (S,R,S)-AHPC-PEG2-C4-Cl；VH032-PEG2-C4-Cl;VHL Ligand-Linker Conjugates 7;E3 ligase Ligand-Linker Conjugates 10 | C32H47ClN4O6S | 1835705-57-1 | Details |
| (S,R,S)-AHPC-(C3-?PEG)?2-?C6-?Cl；VHL Ligand-Linker Conjugates 11;E3 ligase Ligand-Linker Conjugates 11 | C39H61ClN4O6S | 1835705-61-7 | Details |
| Thalidomide-O-amido-C3-COOH；E3 ligase Ligand-Linker Conjugates 15;Cereblon Ligand-Linker Conjugates 7 | C19H19N3O8 | 2308035-51-8 | Details |
| (S,R,S)-AHPC-PEG2-N3 | C28H39N7O6S | 2010159-45-0 | Details |
| (S,R,S)-AHPC-PEG3-N3 | C30H43N7O7S | 1797406-80-4 | Details |
| Pomalidomide-C2-amido-(C1-O-C5-O-C1)2-COOH；E3 ligase Ligand-Linker Conjugates 49;Cereblon Ligand-Linker Conjugates 14 | C31H44N4O11 | 2351103-63-2 | Details |
| cIAP1 Ligand-Linker Conjugates 12；E3 ligase Ligand-Linker Conjugates 38 | C46H64N4O12S2 | 2095244-52-1 | Details |
| cIAP1 Ligand-Linker Conjugates 5；E3 ligase Ligand-Linker Conjugates 39 | C37H55N5O8S | 2113688-20-1 | Details |
| cIAP1 Ligand-Linker Conjugates 3；E3 ligase Ligand-Linker Conjugates 40 | C39 H56 N4 O11 S | 2222354-20-1 | Details |
| cIAP1 Ligand-Linker Conjugates 1；E3 ligase Ligand-Linker Conjugates 41 | C42H57N5O9S | 2357114-75-9 | Details |
| Thalidomide-O-amido-PEG3-C2-NH2；E3 Ligase Ligand-Linker Conjugates 14;Cereblon Ligand-Linker Conjugates 3 | C23H30N4O9 | 1957236-20-2 | Details |
| Fosaprepitant dimeglumine | C30H39F7N5O11P | 265121-04-8 | Details |
| Ceritinib | C28H36ClN5O3S | 1032900-25-6 | Details |
| (S,R,S)-AHPC-C6-PEG3-C4-Cl | C38H59ClN4O7S | 1835705-55-9 | Details |
| Lenalidomide-C5-NH2；E3 ligase Ligand-Linker Conjugates 31;Cereblon Ligand-Linker Conjugates 19 | C18H23N3O3 | 2093388-45-3 | Details |
| EC089 | C36H46N14O14S | 625827-91-0 | Details |
| EC1167 | C33H45N7O17S | 1610414-00-0 | Details |
| endo-BCN-PEG2-C2-NHS ester | C22H30N2O8 | 2243565-12-8 | Details |
| endo-BCN-PEG3-mal | C26H37N3O8 | 2141976-33-0 | Details |
| MBX-2982 | C22H24N8OS | 1037792-44-1 | Details |
| (S,R,S)-AHPC TFA | C24H31F3N4O5S | 1631137-51-3 | Details |
| (S,R,S)-AHPC-PEG4-N3 | C32H47N7O8S | 1797406-81-5 | Details |
| (S,R,S)-AHPC-PEG3-NH2 hydrochloride | C30H46ClN5O7S | 2097971-11-2 | Details |
| Ceritinib dihydrochloride | C28H37Cl2N5O3S | 1380575-43-8 | Details |
| Regorafenib | C21H15ClF4N4O3 | 755037-03-7 | Details |
| (S,R,S)-AHPC-PEG2-NH2；VH032-PEG2-NH2;VHL Ligand-Linker Conjugates 3;E3 ligase Ligand-Linker Conjugates 6 Free Base | C28H41N5O6S | 2010159-60-9 | Details |
| (S,R,S)-AHPC-PEG6-C4-Cl；VHL Ligand-Linker Conjugates 10;VH032-PEG6-C4-Cl;E3 ligase Ligand-Linker Conjugates 9 | C40H63ClN4O10S | 1835705-59-3 | Details |
| (S,R,S)-AHPC-PEG1-N3 | C26H35N7O5S | 2101200-09-1 | Details |
| Thalidomide-O-amido-C6-NH2 TFA | C23H27F3N4O8 | 1950635-14-9 | Details |
| Thalidomide-O-amido-PEG2-C2-NH2 TFA | C23H27F3N4O10 | 1957235-75-4 | Details |
| Pomalidomide-PEG4-C2-NH2 | C23H32N4O8 | 2225940-52-1 | Details |
| (S,R,S)-AHPC-PEG3-NH2；E3 ligase Ligand-Linker Conjugates 5 Free Base;VH032-PEG3-NH2;VHL Ligand-Linker Conjugates 1 | C30H45N5O7S | 2010159-56-3 | Details |
| (S,R,S)-AHPC-PEG2-NH2 hydrochloride | C28H42ClN5O6S | 2097973-72-1 | Details |
| Otenabant hydrochloride | C25H26Cl3N7O | 686347-12-6 | Details |
| Fmoc-N-PEG20-acid | C58H97NO24 | 1952360-93-8 | Details |
| Fmoc-Gly-Gly-OH | C19H18N2O5 | 35665-38-4 | Details |
| Fmoc-NH-PEG12-CH2CH2COOH | C42H65NO16 | 1952360-91-6 | Details |
| Fmoc-Gly-Gly-Phe-OtBu | C32H35N3O6 | 236426-37-2 | Details |
| Fmoc-Asp-NH2 | C19H18N2O5 | 200335-40-6 | Details |
| Fmoc-Ala-Ala-Asn(Trt)-OH | C44H42N4O7 | 1951424-92-2 | Details |
| Carfilzomib | C40H57N5O7 | 868540-17-4 | Details |
| Product Total： Product Page： | ||||
| 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 | ||||